These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19553756)

  • 41. [Which cut-off value of high sensitivity C- reactive protein is more valuable for determining long- term prognosis in patients with acute coronary syndrome?].
    Kiliç T; Ural E; Oner G; Sahin T; Kiliç M; Yavuz S; Kanko M; Kahraman G; Bildirici U; Berki KT; Ural D
    Anadolu Kardiyol Derg; 2009 Aug; 9(4):280-9. PubMed ID: 19666429
    [TBL] [Abstract][Full Text] [Related]  

  • 42. "Poor man's risk factor": correlation between high sensitivity C-reactive protein and socio-economic class in patients of acute coronary syndrome.
    Sethi R; Puri A; Makhija A; Singhal A; Ahuja A; Mukerjee S; Dwivedi SK; Narain VS; Saran RK; Puri VK
    Indian Heart J; 2008; 60(3):205-9. PubMed ID: 19240308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Inflammatory concepts of atherosclerosis--clinical utility of C-reactive protein measurement].
    Gibas M; Miszczak-Smiałek J
    Wiad Lek; 2006; 59(3-4):242-5. PubMed ID: 16813272
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Utility of C-reactive protein measurement in risk stratification during primary cardiovascular disease prevention.
    Bard RL; Rubenfire M; Eagle K; Clarke NS; Brook RD
    Am J Cardiol; 2005 Jun; 95(11):1378-9. PubMed ID: 15904650
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study).
    Brodov Y; Behar S; Goldenberg I; Boyko V; Chouraqui P
    Am J Cardiol; 2009 Jul; 104(2):194-8. PubMed ID: 19576345
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical significance of high-sensitivity C-reactive protein].
    Ueno H
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():137-41. PubMed ID: 16983765
    [No Abstract]   [Full Text] [Related]  

  • 47. C-reactive protein: the harbinger of cardiovascular diseases.
    Abi-Saleh B; Iskandar SB; Elgharib N; Cohen MV
    South Med J; 2008 May; 101(5):525-33. PubMed ID: 18414170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [New biomarkers for cardiovascular risk evaluation].
    Chironi G
    Rev Prat; 2012 Jun; 62(6):783-5. PubMed ID: 22838270
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Biochemical markers of atherosclerotic disease].
    Derić M; Stokić E; Kojić-Damjanov S; Cabarkapa V; Eremić N
    Med Pregl; 2009; 62 Suppl 3():15-23. PubMed ID: 19702111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. C-reactive protein, inflammation, and coronary risk.
    Morrow DA; Ridker PM
    Med Clin North Am; 2000 Jan; 84(1):149-61, ix. PubMed ID: 10685132
    [TBL] [Abstract][Full Text] [Related]  

  • 51. C-reactive protein--to screen or not to screen?
    Mosca L
    N Engl J Med; 2002 Nov; 347(20):1615-7. PubMed ID: 12432050
    [No Abstract]   [Full Text] [Related]  

  • 52. Putting genome analysis to good use: lessons from C-reactive protein and cardiovascular disease.
    Manace LC; Babyatsky MW
    Cleve Clin J Med; 2012 Mar; 79(3):182-91. PubMed ID: 22383552
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elevated C-reactive protein in atherosclerosis--chicken or egg?
    Schunkert H; Samani NJ
    N Engl J Med; 2008 Oct; 359(18):1953-5. PubMed ID: 18971498
    [No Abstract]   [Full Text] [Related]  

  • 54. Predictive ability of coronary artery calcium and CRP.
    Schmermund A; Voigtländer T
    Lancet; 2011 Aug; 378(9792):641-3. PubMed ID: 21856466
    [No Abstract]   [Full Text] [Related]  

  • 55. [Role of C-reactive protein in atherogenesis].
    Boncler M; Luzak B; Watala C
    Postepy Hig Med Dosw (Online); 2006; 60():538-46. PubMed ID: 17060895
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Do we need to consider inflammatory markers when we treat atherosclerotic disease?
    Athyros VG; Kakafika AI; Karagiannis A; Mikhailidis DP
    Atherosclerosis; 2008 Sep; 200(1):1-12. PubMed ID: 18420211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Beyond C-reactive protein; new evidence for another inflammatory biomarker predicting cardiovascular disease risk.
    Kajinami K; Kawai Y
    Atherosclerosis; 2011 Jan; 214(1):39-40. PubMed ID: 21036356
    [No Abstract]   [Full Text] [Related]  

  • 58. The USPSTF recommendation statement on coronary heart disease risk assessment.
    Glynn RJ
    Ann Intern Med; 2010 Mar; 152(6):403; author reply 405-6. PubMed ID: 20231577
    [No Abstract]   [Full Text] [Related]  

  • 59. C-reactive protein as a risk factor versus risk marker.
    de Maat MP; Trion A
    Curr Opin Lipidol; 2004 Dec; 15(6):651-7. PubMed ID: 15529024
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predicting CAD events: C-reactive protein a marker for atherosclerotic risk.
    MacKenzie JR
    Nurse Pract; 2004 Jun; 29(6):14-5, 19-27; quiz 27-9. PubMed ID: 15257119
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.